Brief: Alzinova Initiates Development Of A Stable Cell Line To Prepare The Monoclonal Antibody Alz-201 For Alzheimer's Clinical Trials
24/05/2022 19:10
May 24 (Reuters) - Alzinova AB ALZ.ST :
* ALZINOVA INITIATES DEVELOPMENT OF A STABLE CELL LINE TO
PREPARE
THE MONOCLONAL ANTIBODY ALZ-201 FOR ALZHEIMER'S CLINICAL TRIALS
Source text for Eikon: ID:nPn6Yx76ga
Further company coverage: ALZ.ST
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Alzinova AB
See all newsBrief: Alzinova's Board Resolves On Directed Issue Of Units
Brief: Alzinova Announces Preliminary Outcome Of The Rights Issue
Brief: Alzinova Broadens Shareholder Base With New Investor
Brief: Alzinova Resolves On Rights Issue Of SEK 51 Mln
Brief: Alzinova Q2 Loss After Financial Items At SEK 5.4 Million